Clinical trial · Interventional
Hydrotherapy Against Menopausal Symptoms in Breast Cancer Survivors
Prospective Randomized Feasibility Study on the Self Application of Hydrotherapy to Treat Menopausal Symptoms Caused by Breast Cancer Therapy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Breast cancer survivors often suffer from climacteric symptoms caused by treatment or diagnosis of their disease. Hormone replacement therapy is contraindicated and other pharmacological options may also include the risk of stimulating hormone receptors. Hydrotherapy following the guidelines of naturopathy by S. Kneipp is a non-pharmacological treatment option which may influence climacteric symptoms by affecting the regulation of body temperature. In this study, the regular self application of hydrotherapy after initial training by a professional will be evaluated for its efficacy, practicability, and compatibility.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Amenorrhea | — | UNRESOLVED | — |
| Hot Flashes | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| hydrotherapy according to Kneipp rules | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- immediate treatment group (SBG)
- description
- immediate start of hydrotherapy (self treatment) in immediate treatment group (SBG)
- interventionNames
- Other: hydrotherapy according to Kneipp rules
- type
- NO_INTERVENTION
- label
- waiting group (WG)
- description
- start of hydrotherapy (self treatment) after waiting period of 12 weeks
Primary outcomes (1)
- measure
- Menopausal complaints (MRS II)
- timeFrame
- 12 and 24 weeks
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Breast cancer diagnosis * Menopausal complaints score \> 14 (MRS II) * End of last chemotherapy or radiotherapy \> 2 months * Expected stable disease for the next 6 months Exclusion Criteria: * Regular intake of glucocorticoids * Regular practice of hydrotherapy before inclusion * Start or change of other treatments/changes of lifestyle in order to influence menopausal symptoms * Psychiatric disorders with possible influence on compliance and adherence to the protocol * Other severe or progressive diseases with influence on compliance and adherence to the protocol * Contraindications to hydrotherapy (severe heart failure, relevant dermatological diseases, Raynaud's Phenomenon \[M. Raynaud\], peripheral arterial occlusive disease Fontaine stage IIb \[VK IIb\] or more, acute thrombosis, or thrombophlebitis)
References
Publications (0)
Data not yet available